What is the Difference Between Allosteric Activator and Inhibitor

The main difference between allosteric activator and inhibitor is that an allosteric activator is a molecule that binds to the allosteric site of an enzyme and enhances the enzyme’s activity, whereas an allosteric inhibitor is a molecule that binds to the allosteric site of an enzyme and reduces or inhibits the enzyme’s activity.

Enzymes are the biochemical catalysts that power the chemical reactions essential for life. To ensure that these reactions occur at the right time and in the right place, organisms have evolved a sophisticated system of enzymatic regulation. One main element of this regulation is allosteric activation. This process unlocks the enzymes’ full potential by binding specific molecules at sites distinct from the active site.

Key Areas Covered

1. What is an Allosteric Activator
      – Definition, Characteristics
2. What is an Allosteric Inhibitor
      – Definition, Characteristics
3. Similarities Between Allosteric Activator and Inhibitor
      – Outline of Common Features
4. Difference Between Allosteric Activator and Inhibitor
      – Comparison of Key Differences

Key Terms

Allosteric Activator, Allosteric Inhibitor, Allosteric Activation, Allosteric Inhibition 

Difference Between Allosteric Activator and Inhibitor - Comparison Summary

What is an Allosteric Activator

Allosteric activators are specific molecules that bind to distinct sites on enzymes, known as allosteric sites. This binding triggers a regulatory mechanism called allosteric activation. Unlike the enzyme’s active site, where substrates typically bind for catalysis, allosteric sites are separate regions. When these activators bind to allosteric sites, they induce a conformational change in the enzyme, leading to its activation and enhanced catalytic activity.

One of the most well-known examples of allosteric activation is found in the glycolytic pathway. Phosphofructokinase-1 (PFK-1), a key enzyme in glycolysis, is allosterically activated by molecules like AMP (adenosine monophosphate) or fructose-2,6-bisphosphate. When cellular energy levels are low (indicated by high levels of AMP), PFK-1 becomes more active, allowing for increased glucose breakdown to produce energy. Blood clotting involves a series of enzyme-catalyzed reactions. Thrombin, a central enzyme in this cascade, is allosterically activated by binding to the substrate fibrinogen. This activation ensures the efficient conversion of fibrinogen to fibrin, leading to blood clot formation. Calcium ions (Ca²⁺) allosterically activate the enzyme troponin in muscle cells. This activation is a crucial step in the regulation of muscle contraction. When Ca²⁺ levels rise due to neural stimulation, troponin undergoes a conformational change, allowing the myosin heads to interact with actin and initiate muscle contraction.

Compare Allosteric Activator and Inhibitor

Figure 1: Allosteric Activator and Inhibitor

What is an Allosteric Inhibitor

Allosteric inhibition is a regulatory mechanism by which enzymes are inhibited, or their activity is reduced when specific molecules bind to sites distinct from the enzyme’s active site. These molecules are called allosteric inhibitors, while the binding sites are called allosteric sites. Allosteric sites are separate from the enzyme’s catalytic center.

Allosteric inhibition is a critical regulatory mechanism in various physiological processes, ensuring that metabolic pathways and cellular functions are finely tuned to respond to changing conditions. Here are a few examples illustrating its physiological significance.

Many biosynthetic pathways use feedback inhibition to control the production of specific molecules. For instance, in the biosynthesis of amino acids, the pathway’s end product can act as an allosteric inhibitor of an enzyme earlier in the pathway. This prevents the excessive accumulation of the end product.

In glycolysis, phosphofructokinase-1 (PFK-1) is allosterically inhibited by ATP. When cellular energy levels are high (indicated by elevated ATP levels), PFK-1 becomes less active, slowing down glycolysis and conserving energy.

Blood clotting involves a series of enzyme-catalyzed reactions. Antithrombin, an inhibitor of thrombin and other coagulation enzymes, is allosterically activated by binding to heparin, an anticoagulant. This allosteric activation enhances the inhibition of thrombin and helps regulate blood clotting.

Allosteric sites on enzymes are attractive targets for drug discovery. Designing molecules that bind to allosteric sites and act as inhibitors can lead to the development of novel therapeutic agents. Allosteric inhibitors can offer advantages such as specificity and reduced side effects.

Allosteric inhibition can be harnessed in biotechnology and metabolic engineering to control enzyme activity. It can fine-tune enzymatic reactions for specific purposes, such as optimizing biofuel production or creating biosensors.

Similarities Between Allosteric Activator and Inhibitor

  • Both activators and inhibitors bind to specific allosteric sites on the enzyme.
  • The binding of activators and inhibitors induces conformational changes in the enzyme’s structure.

Difference Between Allosteric Activator and Inhibitor

Definition

An allosteric activator is a molecule that binds to the allosteric site of an enzyme and enhances the enzyme’s activity, whereas an allosteric inhibitor is a molecule that binds to the allosteric site of an enzyme and reduces or inhibits the enzyme’s activity.

Function

Allosteric activators enhance or increase the activity of an enzyme, while allosteric inhibitors reduce or inhibit the activity of an enzyme.

Conformational Change

When an activator binds to the allosteric site, it induces a conformational change in the enzyme’s structure, making the active site more receptive to substrates. When an inhibitor binds to the allosteric site, it induces a conformational change that either distorts the active site or stabilizes an inactive enzyme conformation.

Regulation

Activators increase enzyme activity when specific conditions or signals warrant an enhanced rate of catalysis. Inhibitors reduce enzyme activity when it’s necessary to slow down or halt enzymatic reactions, often to prevent overproduction of certain compounds.

Conclusion

Allosteric activators enhance or increase the activity of an enzyme, while allosteric inhibitors reduce or inhibit the activity of an enzyme. Thus, this is the main difference between allosteric activator and inhibitor.

Reference:

1. “Allosteric Enzyme: Regulation Mechanism and Examples.” Byju’s.
2. “Allosteric Inhibition: Definition, Mechanism, & Examples.” Research Tweet.

Image Courtesy:

1. “Figure 06 05 05” By CNX OpenStax(CC BY 4.0) via Commons Wikimedia

About the Author: Hasini A

Hasini is a graduate of Applied Science with a strong background in forestry, environmental science, chemistry, and management science. She is an amateur photographer with a keen interest in exploring the wonders of nature and science.

Leave a Reply